Literature DB >> 8359200

Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.

B Allard1, M Lazdunski.   

Abstract

The patch-clamp technique (single-channel recordings) was used to study the effects of glibenclamide and some channel openers on the KATP channel in mouse skeletal muscle. In outside/out membrane patches, glibenclamide reversibly inhibited KATP channel activity in a dose-dependent manner with an apparent Ki of 190 nM. In inside/out membrane patches, RP 61419 increased KATP channel activity both in the absence and in the presence of internal ATP while other K+ channel openers such as nicorandil and cromakalim required the presence of internal ATP to evoke channel activation. The half-maximal activity effect for cromakalim, with 0.5 mM ATP at the cytoplasmic face, was observed at about 220 microM. Pinacidil was unable to activate the KATP channel in the absence of internal ATP and could even reduce channel opening in situations where activity was high in the control. In the presence of internal Mg2+, activation by pinacidil occurred when ATP or low and weakly activating concentrations of ADP were present at the cytoplasmic side. Pinacidil activation could also be observed in the presence of ATP or ADP when Mg2+ was absent from the internal solution. The mechanism of action of pinacidil is discussed in terms of interactions between the different nucleotide regulatory sites and the K+ channel opener binding site of the KATP channel. Half-maximum activation of the KATP channel in the presence of 0.5 mM ATP at the cytoplasmic face was observed at 125 microM pinacidil.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359200     DOI: 10.1016/0014-2999(93)90480-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  4-aminopyridine- and dendrotoxin-sensitive potassium channels influence excitability of vagal mechano-sensitive endings in guinea-pig oesophagus.

Authors:  Vladimir P Zagorodnyuk; Bao Nan Chen; Marcello Costa; Simon J H Brookes
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Binding and effect of K ATP channel openers in the absence of Mg2+.

Authors:  Ulrich Russ; Ulf Lange; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 3.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

4.  Biophysical, pharmacological and developmental properties of ATP-sensitive K+ channels in cultured myotomal muscle cells from Xenopus embryos.

Authors:  E Honoré; M Lazdunski
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

Review 5.  Drugs to facilitate recovery of neuromuscular blockade and muscle strength.

Authors:  Yuhji Saitoh
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

6.  Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.

Authors:  D Thuringer; I Cavero; E Coraboeuf
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 7.  ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.

Authors:  Uttio Roy Chowdhury; Peter I Dosa; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2016-04-26       Impact factor: 3.467

8.  Coexistence of two classes of glibenclamide-inhibitable ATP-regulated K+ channels in avian skeletal muscle.

Authors:  M Fosset; B Allard; M Lazdunski
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

9.  Activation of ATP-dependent K+ channels by metabolic poisoning in adult mouse skeletal muscle: role of intracellular Mg(2+) and pH.

Authors:  B Allard; M Lazdunski; O Rougier
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.